1300022I district of columbia partnership for aids progress (DC pfap). Contractor shall conduct support services for the implementation of research protocols that focus on improving and enhancing…
Ended Awarded Last action
- Contract number
- HHSN27200020
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,866,092
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (VTEU) Award Notice · Posted Mar 29, 2012
- Contract value 100% obligated
- $9,866,092.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,063,616 | |
| Change Order | $2,115,728 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,088,345 | |
| Exercise an Option | $1,799,987 | |
| Original award | $1,798,416 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $9,866,092.00 Delivery Order contract to the University of Maryland, Baltimore (UMB) to conduct support services for the implementation of research protocols that focus on improving and enhancing prevention and treatment of HIV/AIDS and its comorbidities. This contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, a master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. UMB is providing a range of research, healthcare, and education services to support this work, which is part of the District of Columbia Partnership for AIDS Progress (DC PFAP) program. The contract does not have a set-aside designation and is set to be completed by September 17, 2022. UMB's parent organization is the University System of Maryland, which provides institutional support and has also received federal contract and grant funding for telecommunications, research, and student support services.
Description
1300022I district of columbia partnership for aids progress (DC pfap). Contractor shall conduct support services for the implementation of research protocols that focus on improving and enhancing prevention and treatment of HIV/aids and its comorbidities.
Quick answers
Who was awarded contract HHSN27200020?
HHSN27200020 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 18, 2017.
How much is contract HHSN27200020 worth?
The government has obligated $9,866,092 on HHSN27200020.
Is contract HHSN27200020 an order under another contract?
Yes. HHSN27200020 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200020 competed?
The extent of competition for HHSN27200020 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award